Literature DB >> 10027376

Evaluation of a protocol for the non-operative management of perforated peptic ulcer.

C Marshall1, P Ramaswamy, F G Bergin, I L Rosenberg, D J Leaper.   

Abstract

BACKGROUND: The non-operative management of perforated peptic ulcer has previously been shown to be both safe and effective although it remains controversial. A protocol for non-operative management was set up in this hospital in 1989. Adherence to the guidelines in the protocol has been audited over a 6-year period with a review of outcome.
METHODS: The case-notes of patients with a diagnosis of perforated peptic ulcer were reviewed. Twelve guidelines from the protocol were selected for evaluation of compliance to the protocol.
RESULTS: Forty-nine patients underwent non-operative treatment initially. Eight patients failed to respond and underwent operation. Complications included abscess formation (seven patients), renal failure (one), gastric ileus (one), chest infection (two), and cardiac failure and stroke (one). Four deaths occurred in this group. Adherence to certain protocol guidelines was poor, notably those concerning prevention of thromboembolism, use of antibiotics, use of contrast examination to confirm the diagnosis and referral for follow-up endoscopy. Two gastric cancers were detected on subsequent endoscopy.
CONCLUSION: This experience demonstrates that non-operative treatment can be used successfully in a general hospital. Adherence to protocol guidelines was found to be variable and the protocol has therefore been simplified. This study highlights the need for an accurate diagnosis and the importance of follow-up endoscopy.

Entities:  

Mesh:

Year:  1999        PMID: 10027376     DOI: 10.1046/j.1365-2168.1999.00982.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Surgical management of perforated peptic ulcer disease.

Authors:  K J Sweeney; M O Faolain; D Gannon; T F Gorey; M J Kerin
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

2.  Operations for peptic ulcer disease: paradigm lost.

Authors:  W H Schwesinger; C P Page; K R Sirinek; H V Gaskill; G Melnick; W E Strodel
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

Review 3.  [Ulcer surgery - what remains?].

Authors:  A H Hölscher; E Bollschweiler; S P Mönig
Journal:  Internist (Berl)       Date:  2006-06       Impact factor: 0.743

4.  Perforated duodenal ulcer in high risk patients: is percutaneous drainage justified?

Authors:  Aly Saber; Mohammad A Gad; Gouda M Ellabban
Journal:  N Am J Med Sci       Date:  2012-01

5.  A Non-invasive 24 Hours Stabilization of Duodenal Ulcer Perforation by a Combination Regimen.

Authors:  Ahsan Zil-E-Ali; Muhammad Bin Shafique; Salman Assad; Hammad Ali; Usman Ghani
Journal:  Cureus       Date:  2016-12-01

Review 6.  Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference.

Authors:  Massimo Sartelli; Fausto Catena; Fikri M Abu-Zidan; Luca Ansaloni; Walter L Biffl; Marja A Boermeester; Marco Ceresoli; Osvaldo Chiara; Federico Coccolini; Jan J De Waele; Salomone Di Saverio; Christian Eckmann; Gustavo P Fraga; Maddalena Giannella; Massimo Girardis; Ewen A Griffiths; Jeffry Kashuk; Andrew W Kirkpatrick; Vladimir Khokha; Yoram Kluger; Francesco M Labricciosa; Ari Leppaniemi; Ronald V Maier; Addison K May; Mark Malangoni; Ignacio Martin-Loeches; John Mazuski; Philippe Montravers; Andrew Peitzman; Bruno M Pereira; Tarcisio Reis; Boris Sakakushev; Gabriele Sganga; Kjetil Soreide; Michael Sugrue; Jan Ulrych; Jean-Louis Vincent; Pierluigi Viale; Ernest E Moore
Journal:  World J Emerg Surg       Date:  2017-05-04       Impact factor: 5.469

7.  Delayed surgery in a patient with pneumococcal peritonitis and bacteremia secondary to perforation of gastroduodenal ulcer: A case report.

Authors:  Gwenola Allain-Jeannic; Nicolas Traversier; Olivier Belmonte; Dorothée Valance; Sarah Bekkar; Nicolas Allou; Jerome Allyn
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.